City
Epaper

Covid vaccination plan ambitious yet realistic, says DST's Dr Ashutosh Sharma

By ANI | Updated: May 31, 2021 11:15 IST

The Centre's COVID-19 vaccination plan to innoculate all citizens of the country by December 31 is not only ambitious but also realistic, said Dr Ashutosh Sharma, Secretary, Department of Science and Technology.

Open in App

The Centre's COVID-19 vaccination plan to innoculate all citizens of the country by December 31 is not only ambitious but also realistic, said Dr Ashutosh Sharma, Secretary, Department of Science and Technology.

"In terms of technology, we are totally prepared for the third wave and would get even better as we go forward this year. Our vaccination plan to innoculate all citizens of the country by December is not only ambitious but also realistic," Dr Sharma toldon Sunday.

"During the first wave, we built a huge infrastructure which was related to basic things like ventilator, all kinds of diagnostics, PPE kits, N-95 masks, now we even have a vaccine which is of Indian origin. In addition to setting up the infrastructure for vaccine, cold chain, the supply lines, logistics, all have been put together quickly in the first wave," Dr Sharma said.

He added, "the second wave was rather sudden and we found that certain things were missing and that was not as much available in quantity as was needed at the peak of the second wave."

Speaking about the innovation related to oxygen supply, he said many innovations have been done related to the oxygen supply like repurposing many oxygen plants where plants that were producing industrial oxygen have been repurposed for the medical oxygen.

As India battles the second wave of the coronavirus pandemic science-based start-ups and innovations are playing a crucial role.

Speaking on innovation related to RT-PCR testing, the doctor said that new RT-PCR from Sree Chitra Tirunal Institute for Medical Sciences and Technology targets two genes, one of which does not undergo many mutations. "So, we will not produce false RT-PCR readings as much as otherwise might happen."

"An antibody kit has been developed at Indian Institute of Science, Bangalore. lt looks at antibodies IgM and IgG. The kit measures the quantity of antibodies. It also determines if they are fading." Dr Sharma added.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: indiabangaloreSree Chitra Tirunal Institute For Medical Sciences And TechnologyDepartment of science and technologyNodal departmentIndiUk-indiaScience and innovation blade nzimandeRepublic of indiaDepartment of science and technology of india
Open in App

Related Stories

NationalGoa: Bengaluru Tourist Attacked with Rods at Calangute Beach, Shack Workers Arrested (Watch

InternationalIranian President Calls for Constructive Role of Brics to Halt West Asia Conflict During Talks With PM Modi

LifestyleEid 2026 Date: When Will Saudi Arabia, UAE and India Celebrate Eid-ul-Fitr?

MaharashtraMaharashtra CM Devendra Fadnavis Unfurls 200-Foot National Flag at Nagpur’s Kasturchand Park

NationalAhmedabad Traffic Update for India vs New Zealand T20 World Cup Final: Check Road Closures and Alternate Routes Near Narendra Modi Stadium

National Realted Stories

NationalJamiat’s remarks against us are ‘deeply unfortunate’: AIMIM

National‘I dedicate my life to him’: Anoop Antony on PM Modi's praise

NationalHeroin valued at Rs 2.10 crore seized in Assam; three held

NationalNHRC member Priyank Kanoongo seeks probe into FSSAI document leak, role of accused

NationalHimachal CITU chief slams move to discontinue 10% annual hike for SEHB workers